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About IBI
• National, not-for-profit membership 
organization
• 550+ corporate sponsors
• Employers: 85% of IBI’s members
• IBI’s mission: Demonstrate the business value of 
a healthy workforce through independent HPM 
research to point the way, measurement and 
modeling tools to help get there, and a forum for 
sharing ideas and experience.
• Visit www.ibiweb.org
New Employer Realities
• Show the C-suite the value of improved 
workforce health
• Healthcare reform: the value of a healthy 
workforce or the cost of healthcare?
• Dead end: attempting to control claims costs 
in separate program silos
• Looking for best strategies to improve  
workforce health, reduce lost time, and 
enhance  productivity
• Limited data, time, and dollars
Up the Organization
The View from the C-Suite
On the Brink of Change
How CFOs View Investments 
in Health and Productivity
IBI Research, 2002
Linking Health, Productivity and 
the Bottom Line
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Source: On the Brink of Change – How CFOs View Investments in Health and Productivity. Integrated 
Benefits Institute. 2002.
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Effect of Benefits Programs on 
Financial Performance
A big deal 
for only 25%
Source: On the Brink of Change – How CFOs View Investments in Health and Productivity. 
Integrated Benefits Institute. 2002.
The Business Value of Health
Linking CFOs to Health and 
Productivity
IBI Research, 2006
The Impact of Ill-Health
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Source: The Business Value of Health: Linking CFOs to Health and Productivity, IBI, 2006
Are CFOs Getting Information?
• Absence
– 51% ever get reports on occurrence
– 22% get reports on financial impact
• Presenteeism
– 22% ever get reports on occurrence
– 8% get reports on financial impact
Source: The Business Value of Health: Linking CFOs to Health and Productivity, IBI, 2006
Lost Productivity Costs a 
Function of ….
• Ability to replace workers
• Time value of output
• Degree of team work
Source: Sean Nicholson, Mark Pauly, et al., "Measuring the Effects of Work Loss on 
Productivity with Team Production," Health Economics 15: 111-123 (2006).
How CFOs Would Use Lost-
productivity Information
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Source: The Business Value of Health: Linking CFOs to Health and Productivity, IBI, 2006
New Research
Health and Productivity as a Business 
Strategy: A Multiemployer Study*
* Source: Journal of Occupational and Environmental Medicine. Vol. 51, No. 4, April 2009
Database Structure – Phase II
• Three unique databases
– 1,045,552 medical claims
– 413,110 pharmacy claims
– 34,622 employee self reports
• Creating an integrated database
– Mapping pharmacy claims to medical 
claims
– Mapping self reports to 
medical/pharmacy claims
Full Costs – Medical, Pharmacy, 
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Co-Morbidity and Lost Time
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The Impact of Pharmaceutical 
Plan Design
IBI Research
2007
Ave. Medication Adherence
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Disease Modifying Symptom Relieving
Impact on Lost Productivity Costs
-- No Script Group --
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What can we learn about 
Diabetes from the HPQ/HPQ-
Select Database?
Preliminary Analysis
2010
Persons with Diabetes have more 
Chronic Conditions 
(Self-reported Diabetes 4% Prevalence)
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Top Ten Chronic Conditions Among 
Persons with Diabetes
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Percent with Only Diabetes vs. Other 
Conditions in addition to Diabetes
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(n=4432), 89.4%
Only Diabetes 
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Work Outcomes among those with Diabetes
Those in 
treatment have 
higher job 
performance
No significant effect
In Current 
Treatment
As comorbidity 
increases, job 
performance 
declines
As comorbidity 
increases, absence 
increases
Number of 
Illnesses
Job 
PerformanceAbsence
What can we learn about 
Diabetes from the IBI 
Benchmarking Database?
Preliminary Analysis
2010
CY Lost Workdays per Active STD Claim
(IBI Benchmarking Data, 2008)
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(IBI Benchmarking Data, 2008)
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Contact IBI
Kimberly Jinnett, PhD
Research Director
kjinnett@ibiweb.org
www.ibiweb.org
www.benefitsintelligence.org
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